InvestorsHub Logo
Followers 22
Posts 2363
Boards Moderated 1
Alias Born 09/10/2014

Re: None

Friday, 04/20/2018 2:26:17 PM

Friday, April 20, 2018 2:26:17 PM

Post# of 30141
In a joint statement with former Massachusetts governor, William Weld, Boehner stressed the need to federally deschedule marijuana so that proper research can be done on the plant. The pair also recognized its potential use in treating our veterans and helping curb the opioid epidemic.

I agree, one of the most important steps we can take in furthering research into medical marijuana and its components like CBD is to decriminalize it on a national level, removing it from the list of narcotics, where it currently sits with the likes of heroin and cocaine.

The federal government needs to endorse the medical marijuana industry to further conduct important research and make it available to patients who are not responding to synthetic medications or other treatments.

This seems like a no-brainer, since the federal government actually owns U.S. Patent No. 6,630,507 – granted in 2003 to the U.S. Department of Health and Human Services – for the “potential use of non-psychoactive cannabinoids to protect the brain from damage or degeneration caused by certain diseases.”

One of the most promising moves I have seen recently when it comes to marijuana research is federal advisers recommending approval for the first CBD medicine (Epidiolex) to treat epilepsy. It was a unanimous decision and the FDA has indicated that it will approve the drug.

It’s high time that Congress realize that when a group of federal scientific advisers -- as well as the FDA -- is willing to approve a marijuana derivative to treat a debilitating disease like epilepsy, it’s also time to let scientists continue to further legitimate research without fear of going to prison.

http://www.foxnews.com/opinion/2018/04/20/420-and-medical-marijuana-now-s-time-to-unleash-power-pot.amp.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.